The most immature infants: Is evidence-based practice possible?

Keith J Barrington1

  • 1CHU Sainte Justine, Montréal, Québec, Canada.

Seminars in Perinatology
|December 13, 2021
PubMed

Insights

Evidence for caring for extremely premature infants is limited. Randomized controlled trials (RCTs) often exclude these vulnerable infants, hindering effective treatment decisions for neonates under 25 weeks gestational age (GA).

Area of Science:

  • Neonatal Medicine
  • Clinical Trials
  • Evidence-Based Practice

Background:

  • Infants born at extremely low gestational ages (<25 weeks) are physiologically immature.
  • Their responses to clinical interventions may differ significantly from more mature preterm infants.
  • Decisions for their care rely on limited available evidence.

Purpose of the Study:

  • To assess the evidence base for clinical care decisions in extremely immature preterm infants.
  • To evaluate the representation of infants <25 weeks gestational age in recent neonatal randomized controlled trials (RCTs).

Main Methods:

  • Literature search of recent large neonatal RCTs.
  • Analysis of infant representation by gestational age, specifically focusing on infants <25 weeks.
  • Examination of whether trial results were presented for the most immature infants.

Main Results:

  • Many recent RCTs excluded extremely immature infants (<25 weeks GA).
  • Of over 25,000 infants (<32 weeks GA) in 30 trials, only 8 reported outcomes for <26 weeks GA (2,152 infants) and 4 for <25 weeks GA (711 infants).
  • Results for the most at-risk, immature infants were rarely presented separately.

Conclusions:

  • The evidence base for treating extremely preterm infants (<25 weeks GA) is severely limited.
  • RCTs should include, not exclude, the most immature infants, regardless of gestational age or weight.
  • Separate reporting of results for infants aged 22-24 weeks GA is crucial for developing effective treatments.
Abstract